Pharmafile Logo
Pharmafocus logo
Advanced Search

Johnson & Johnson

Showing 15 posts of 137 posts found.

Millions more OTC products recalled by J&J

November 29, 2010
Manufacturing and Production Benadryl Allergy Fastmelt, J&J, JJ, Johnson & Johnson, Motrin, Rolaids, Tylenol, manufacturing compliance, recalls

Johnson & Johnson has been forced to announce yet another recall of over-the-counter medicines manufactured at its Fort Washington facility …

News

J&J and Takeda issue recall for cancer drug Velcade

November 22, 2010
Manufacturing and Production J&J, JJ, Johnson & Johnson, Takeda Pharmaceuticals, Velcade, bortezomib, pharma manufacturing, product recalls

Johnson & Johnson has been affected by another product recall, on this occasion concerning the cancer drug Velcade (bortezomib) sold …

News

Pharma engages HTA bodies in early-stage drug discussions

October 27, 2010
Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, EMA, European Medicines Agency, GlaxoSmithKline, Johnson & Johnson, health technology assessment, hta

Three pharma companies are taking part in a new pilot to harmonise European standards in health technology assessment (HTA). AstraZeneca, …

News
Johnson & Johnson Tylenol

Johnson & Johnson recalls more Tylenol

October 21, 2010
Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, Tylenol, pharma recalls, product recalls

Johnson & Johnson’s McNeil Consumer Healthcare unit has announced yet another recall affecting its Tylenol painkiller range. The latest recall …

News

Cutting-edge cancer treatments showcased at ESMO

October 18, 2010
Research and Development AstraZeneca, Boehringer, Cancer, Cancer Conference, Johnson & Johnson, Novartis, personalised medicine

The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …

Feature

J&J chief admits mistakes at Congressional hearing

October 1, 2010
Sales and Marketing Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson chief executive William Weldon admitted yesterday that his company had failed to maintain quality standards and mishandled …

News

J&J’s Weldon will appear at next congressional hearing

September 21, 2010
Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson chief executive William Weldon will appear in person at the next congressional hearing on the company’s wide-ranging …

News

J&J to acquire Crucell for $2.3 billion

September 17, 2010
Sales and Marketing Crucell, Johnson & Johnson

Johnson & Johnson is set to buy out Crucell for around $2.3 billion (1.75 bn euros) expanding its presence in …

News

J&J and Merck heading for showdown over drug rights

September 8, 2010
Sales and Marketing Johnson & Johnson, Merck, Remicade

Johnson & Johnson’s disagreement with Merck over rights to two arthritis drugs is set to come to a head in …

News

J&J recall plant will be closed all year

June 29, 2010
Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance

The manufacturing facility at the centre of Johnson & Johnson’s product recall woes is likely to stay closed until at …

News

Congress summons J&J chief executive

June 23, 2010
Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance

The Congressional committee looking into the recalls ordered by Johnson & Johnson unit McNeil Consumer Healthcare is planning to hold …

News

J&J expands recall of ‘musty’ products

June 18, 2010
Manufacturing and Production Johnson & Johnson, manufacturing compliance

Johnson & Johnson’s manufacturing troubles continues to build with yet another recall announced this week, this time for additional lots …

News

‘Phantom recall’ dogs J&J at congressional hearing

June 1, 2010
Manufacturing and Production Johnson & Johnson, McNeil, Tylenol, manufacturing compliance

Johnson & Johnson subsidiary McNeil Consumer Healthcare initiated a recall of its painkiller Motrin (ibuprofen) last year without informing the …

News

Congress to probe McNeil’s GMP violations

May 7, 2010
Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance

The US Food and Drug Administration may take additional regulatory action against Johnson & Johnson subsidiary McNeil Consumer Healthcare over …

News

More quality issues dog J&J

May 5, 2010
Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson’s manufacturing is under the spotlight at the FDA once again for quality issues affecting its products. At …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024